[Recent advance in the treatment of hypertension].
Nagasawa
K
K
First Department of Internal Medicine, Nippon Medical School.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D000075202:Contraindications; D004032:Diet; D004232:Diuretics; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000628:therapy*; D008297:Male; D011247:Pregnancy; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013695:Temperance
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors